Insulin Monotard MC: description, manufacturers and dosage forms
Insulin Monotard MC is an intermediate-acting insulin that is used in the treatment of diabetes mellitus. It is produced by several companies, including Bryntsalov (Russia), Novo Nordisk A/O (Denmark), Torrent Pharmaceuticals (India) and Ferein (Russia).
Insulin Monotard MC is an injection suspension with a concentration of 40 IU/ml or 40 IU/ml. It has the international name Insulin-SrD and a wide list of synonyms, including B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch, Brinsulmidi ChSP, V-Insulin SC Berlin-Chemie, Depo-Insulin S, Isofan Insulin and Isofan Insuli.
Insulin Monotard MC is used to control blood glucose levels in patients with diabetes mellitus. It is suitable for use by both adults and children. Typically, insulin Monotard MC is administered once a day, usually in the evening before bedtime, to ensure continuous action throughout the night and morning period.
Insulin Monotard MC is one of the most common intermediate-acting insulin preparations. It helps patients with diabetes control their blood glucose levels and reduce the risk of complications. However, like any other drug, insulin Monotard MC should only be used under the supervision of a physician and in accordance with the individual needs of the patient.
Thus, insulin Monotard MC is an effective insulin that helps control blood glucose levels in patients with diabetes. It is represented by several manufacturers and is available as an injection suspension with a concentration of 40 IU/ml or 40 IU/ml. When using insulin Monotard MC, you must follow your doctor's instructions and regularly monitor your blood glucose levels.